Sq Innovation Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SQ INNOVATION
SQ INNOVATION has one approved drug.
There are three US patents protecting SQ INNOVATION drugs.
Summary for Sq Innovation
| US Patents: | 3 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Sq Innovation
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sq Innovation | LASIX ONYU | furosemide | SOLUTION;SUBCUTANEOUS | 217294-001 | Oct 7, 2025 | RX | Yes | Yes | 11,246,851 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Sq Innovation | LASIX ONYU | furosemide | SOLUTION;SUBCUTANEOUS | 217294-001 | Oct 7, 2025 | RX | Yes | Yes | 12,318,363 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Sq Innovation | LASIX ONYU | furosemide | SOLUTION;SUBCUTANEOUS | 217294-001 | Oct 7, 2025 | RX | Yes | Yes | 12,403,120 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Sq Innovation Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 2020141224 | ⤷ Start Trial |
| China | 113271923 | ⤷ Start Trial |
| European Patent Office | 3906019 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
